发明名称 4[4-klor-5(3-fluor-4-metoksyfenyl)imidazol-1-yl]benzensulfonamid og farmasøytisk aksepterbare salterderav
摘要 Compounds of formula I wherein: one of X or Y represents N and the other represents C; R1 represents hydrogen, methyl, halogen, cyano, nitro, -CHO, -COCH3 or -COOR4; R2 represents optionally-substituted aryl or heteroaryl; R3 represents C1-8 alkyl, C1-8 haloalkyl or -NR4R6; R4 represents hydrogen, C1-8 alkyl or arylC0-8 alkyl; R6 represents hydrogen, C1-8 alkyl, arylC1-8 alkyl, -COR8 or -COOR8; R8 represents C1-8 alkyl or C1-8 haloalkyl; aryl in the above definitions represents phenyl or naphthyl; and heteroaryl in the above definitions represents pyridine, pyrazine, pyrimidine or pyridazine, which can be optionally fused to a benzene ring. These compounds are useful as cyclooxygenase-2 inhibitors. <CHEM>
申请公布号 NO2011012(I2) 申请公布日期 2013.05.06
申请号 NO20110000012C 申请日期 2011.07.27
申请人 PALAU PHARMA SA 发明人
分类号 C07D233/60;A61K31/4164;A61K31/4427;A61K31/4439;A61P1/00;A61P9/10;A61P11/00;A61P11/06;A61P15/00;A61P21/02;A61P25/08;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07D233/54;C07D233/64;C07D233/68;C07D233/90;C07D401/04 主分类号 C07D233/60
代理机构 代理人
主权项
地址